BTL

Prague – September 08, 2026 -- BTL has formally established a dedicated laser division and confirmed the upcoming launch of EXOLASE ONE®, a system it describes as the first medical application of fused erbium laser technology, treating an entire face in under 10 minutes.

BTL creates sixth core division to house new laser technology

The laser unit becomes BTL's sixth main division, joining existing operations in aesthetics, mental wellness, rehabilitation, cardiology and robotics. The move marks a structural expansion for the medical and aesthetic technology group as it pushes into a new laser hardware category.

Prague – September 08, 2026 -- BTL has established a dedicated laser division and will launch its flagship EXOLASE ONE system, the first medical application of fused erbium laser technology, marking the company's sixth core business line.

EXOLASE ONE merges multiple erbium wavelengths into a single beam

The system combines several erbium laser wavelengths into one light beam, treating the same tissue location simultaneously. BTL states this creates a new form of laser-tissue interaction that overcomes prior limitations in clinical efficacy, treatment speed and patient comfort for facial rejuvenation lasers.

Clinical researcher reports full-face treatment in under 10 minutes

Dr. Reha Yavuzer, one of the first clinical researchers on the platform, said the technology covers treatment areas that typically require multiple ablative and non-ablative systems, condensing the procedure into a full-face treatment completed in under 10 minutes.